S&P 500 7,736 -0.17% Nasdaq 26,443 -0.55% Dow Jones 53,561 -0.39% FTSE 100 10,743 -0.83% DAX 26,091 -0.91% Nikkei 225 65,326 -4.37% Hang Seng 25,495 +0.22% WTI Crude 85.34 +3.57% Gold 4,555 +3.98% US 10-Year Treasury Yield 4.653 +0.26% S&P 500 7,736 -0.17% Nasdaq 26,443 -0.55% Dow Jones 53,561 -0.39% FTSE 100 10,743 -0.83% DAX 26,091 -0.91% Nikkei 225 65,326 -4.37% Hang Seng 25,495 +0.22% WTI Crude 85.34 +3.57% Gold 4,555 +3.98% US 10-Year Treasury Yield 4.653 +0.26%

LATEST

Turnspire snaps up rail services provider Hulcher●Ethereum engineering firm Nethermind leaves LayerZero verifier role for Chainlink●Exclusive: TJC to launch sale of Dental365 in 2027, sources say●Coinbase Adds 50x Crypto Perps to Base App Through Hyperliquid●Standard Chartered analyst eyes $100K BTC as US Treasury doubles long-end buybacks●UK Inflation Jumps to 2.9% as Energy Bills Bite●Jim Cramer says buy Target on any pullback as turnaround takes hold●Here’s Why Investors May Want To Own NetEase Before August 20th●Turnspire snaps up rail services provider Hulcher●Ethereum engineering firm Nethermind leaves LayerZero verifier role for Chainlink●Exclusive: TJC to launch sale of Dental365 in 2027, sources say●Coinbase Adds 50x Crypto Perps to Base App Through Hyperliquid●Standard Chartered analyst eyes $100K BTC as US Treasury doubles long-end buybacks●UK Inflation Jumps to 2.9% as Energy Bills Bite●Jim Cramer says buy Target on any pullback as turnaround takes hold●Here’s Why Investors May Want To Own NetEase Before August 20th●

Asia

Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial

Markets-Economic Times · 1h ago · 🇮🇳 India

Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial

Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This marks the first successful late-stage trial for an mRNA cancer vaccine. The findings offer hope for future growth beyond COVID-19 vaccines. Discussions with regulators are expected within the next few months.

Read the full story at Markets-Economic Times →

More Asia

Indian fintech Navi to raise $100 million ahead of planned IPO

Latest News · 23m ago

Estee Lauder bets on fragrances and skincare to deliver strong annual profit

Markets-Economic Times · 30m ago

US dollar falls to lowest level since late May after Treasury doubles bond buybacks

mint - markets · 35m ago

Sebi bars two entities from markets over manipulation in CAS, orders ₹3.68 crore disgorgement

mint - markets · 38m ago